Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cnbx Pharmaceuticals Inc (CNBX)

Cnbx Pharmaceuticals Inc (CNBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0053 +13.21%
on 12/16/24
0.0120 -50.00%
on 12/09/24
-0.0032 (-34.78%)
since 11/19/24
3-Month
0.0050 +20.00%
on 10/28/24
0.0199 -69.85%
on 10/21/24
-0.0011 (-15.49%)
since 09/20/24
52-Week
0.0050 +20.00%
on 10/28/24
0.0199 -69.85%
on 10/21/24
-0.0063 (-51.22%)
since 12/20/23

Most Recent Stories

More News
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0060 (-14.29%)
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

/PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0060 (-14.29%)
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the...

CNBX : 0.0060 (-14.29%)
CNBX Pharmaceuticals Announces New Patent Granted in Australia

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0060 (-14.29%)
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0060 (-14.29%)
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0060 (-14.29%)
CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0060 (-14.29%)
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0060 (-14.29%)

Business Summary

American Mining Corp was incorporated on September 15, 2004. The Company is an exploration stage company. The Company acquires mineral exploration rights throughout North America, exploring for commercially producible quantities of minerals, and exploiting any mineral deposits which demonstrate economic...

See More

Key Turning Points

3rd Resistance Point 0.0068
2nd Resistance Point 0.0067
1st Resistance Point 0.0063
Last Price 0.0060
1st Support Level 0.0058
2nd Support Level 0.0057
3rd Support Level 0.0053

See More

52-Week High 0.0199
Fibonacci 61.8% 0.0142
Fibonacci 50% 0.0125
Fibonacci 38.2% 0.0107
Last Price 0.0060
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar